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Abstract
Background
Joint reminiscence groups, involving people with dementia and family carers together, are
popular, but the evidence-base is limited. This study aimed to assess the effectiveness and
cost-effectiveness of joint reminiscence groups as compared to usual care.
Methods
This multi-centre, pragmatic randomised controlled trial had two parallel arms: intervention
group and usual-care control group. A restricted dynamic method of randomisation was
used, with an overall allocation ratio of 1:1, restricted to ensure viable sized intervention
groups. Assessments, blind to treatment allocation, were carried out at baseline, three
months and ten months (primary end-point), usually in the person's home. Participants
were recruited in eight centres, mainly through NHS Memory Clinics and NHS community
mental health teams. Included participants were community resident people with mild to
moderate dementia (DSM-IV), who had a relative or other care-giver in regular contact, to
act as informant and willing and able to participate in intervention. 71% carers were
spouses. 488 people with dementia (mean age 77.5)were randomised: 268 intervention,
220 control; 350 dyads completed the study (206 intervention, 144 control). The intervention
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evaluated was joint reminiscence groups (with up to 12 dyads) weekly for twelve weeks;
monthly maintenance sessions for further seven months. Sessions followed a published
treatment manual and were held in a variety of community settings. Two trained facilitators
in each centre were supported by volunteers. Primary outcome measures were self-
reported quality of life for the person with dementia (QoL-AD), psychological distress for the
carer (General Health Questionnaire, GHQ-28). Secondary outcome measures included:
autobiographical memory and activities of daily living for the person with dementia; carer
stress for the carer; mood, relationship quality and service use and costs for both.
Results
The intention to treat analysis (ANCOVA) identified no differences in outcome between the
intervention and control conditions on primary or secondary outcomes (self-reported QoL-
AD mean difference 0.07 (-1.21 to 1.35), F = 0.48, p = 0.53). Carers of people with dementia
allocated to the reminiscence intervention reported a significant increase in anxiety on a
General Health Questionnaire-28 sub-scale at the ten month end-point (mean difference
1.25 (0.25 to 2.26), F = 8.28, p = 0.04). Compliance analyses suggested improved autobio-
graphical memory, quality of life and relationship quality for people with dementia attending
more reminiscence sessions, however carers attending more groups showed increased
care-giving stress. Economic analyses from a public sector perspective indicated that joint
reminiscence groups are unlikely to be cost-effective. There were no significant adverse
effects attributed to the intervention. Potential limitations of the study include less than opti-
mal attendance at the group sessions—only 57% of participants attended at least half of the
intervention sessions over the 10 month period, and a higher rate of study withdrawal in the
control group.
Conclusions
This trial does not support the clinical effectiveness or cost-effectiveness of joint reminis-
cence groups. Possible beneficial effects for people with dementia who attend sessions as
planned are offset by raised anxiety and stress in their carers. The reasons for these dis-
crepant outcomes need to be explored further, and may necessitate reappraisal of the
movement towards joint interventions.
Trial Registration
ISRCTN Registry ISRCTN42430123
Introduction
There is increasing recognition that in dementia care psychosocial interventions may have com-
parable value to pharmacological approaches [1,2] and may be preferable in some contexts, e.g.
where medication may be ineffective or have negative side-effects [3,4], as long as there is no
additional strain on family carers [5]. Despite reminiscence being the most popular therapeutic
approach to working with people with dementia, there is little evidence on effectiveness and
cost-effectiveness. Reminiscence work with people with dementia has an extensive history [6],
engendering enjoyable activities that promote communication and well-being. Reminiscence
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works with early memories, often intact in dementia, drawing on preserved abilities, rather than
emphasising impairments. A Cochrane review on reminiscence therapy for people with demen-
tia [7] did not identify any rigorous trials or economic analyses in this field. All four randomised
controlled trials (RCTs) suitable for analysis were small or of poor quality and each examined
different types of reminiscence work. One of the two studies that were group-based included
family carers in the groups, in line with a meta-analysis on interventions with family carers of
people with dementia suggesting that joint approaches may be more effective in improving
carer outcomes than approaches targeted only at the carer [5]. The trials together identified sig-
nificant improvements in cognition and mood 4–6 weeks after treatment, and reduced stress in
carers participating with the person with dementia in a reminiscence group. Recent reminis-
cence research [8–10] has not involved family carers with people with dementia, making use of
technology-based reminiscence or evaluating groups in a care home context. The National
Institute for Health and Care Excellence and Social Care Institute for Excellence (NICE-SCIE)
Guideline on dementia [3] found insufficient evidence to recommend reminiscence therapy,
although its potential impact on mood of the person with dementia was highlighted. The aim of
our REMCARE trial was to evaluate a specific, promising form of reminiscence work, avoiding
the methodological limitations of previous work. Thus we set out to assess the effectiveness and
cost-effectiveness of joint reminiscence groups for both people with dementia and their carers
as compared with usual care.
Methods
Design
The design was a pragmatic eight-centre randomised trial (Fig 1) with two parallel arms: an
intervention group, and a control group receiving care as usual. Assessments, blind to treat-
ment allocation, were carried out at baseline, three months and ten months (the primary end
point). Randomisation used a dynamic allocation method [11] stratifying for spousal or non-
spousal relationship of the dyad. Complete list randomisation for each wave of recruitment
within each centre was completed. Randomisation was carried out remotely by the NWORTH
accredited Clinical Trials Unit, initiated by a local researcher who did not take part in follow-
up assessments. This researcher arranged for those pairs (up to 12) randomised to the interven-
tion group to attend sessions, and liaised with the group facilitator. Though participants could
not be blinded to their allocated treatment, all follow-up data were gathered by blinded inter-
viewers. In order to reduce the risk of participants occasionally and inadvertently unblinding
researchers, explicit reminders were given to participants before assessment visits and self-
report measures were used wherever feasible. Assessors were also asked to record their impres-
sion of the arm to which each participant belonged so that any bias could be detected. A
favourable ethical opinion was given by the Multi-centre Research Ethics Committee for Wales
(ref no. 07/MRE09/58).
Participants
Recruitment took place through mental health services for older people in each area especially
Memory Clinics and Community Mental Health Teams for Older People, associated day ser-
vices and voluntary sector agencies such as the Alzheimer’s Society, Dementia UK and Age
Concern in the areas Bangor, Bradford, London, Manchester, Newport and Hull. Recruitment
took place in three to five waves in each centre, between June 2008 and July 2010. Assessments
were usually carried out in the person‘s home, and treatment groups held in a variety of com-
munity settings. Participants were 488 people (mean age 77.5) with dementia initially living in
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the community. Most carers were spouses (71%). 350 dyads completed the study. Participants
were free to seek additional assistance and support elsewhere at any time after baseline.
Inclusion criteria
To be included in the study, participants had to: have mild/moderate dementia diagnosed
using DSM-IV criteria; be able to communicate and understand communication, to some
degree (score of 1 or 0 on specific items of the Clifton Assessment Procedures for the Elderly—
Behaviour Rating Scale [12]); be able to engage in group activity; live in the community; have a
Fig 1. Consort diagram of participant flow through study.
doi:10.1371/journal.pone.0152843.g001
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relative or other carer who could act as an informant, and was willing and able to participate in
the joint intervention; not have any serious problem which could undermine participation (e.g.
major physical or sensory disabilities, learning disability, or severe agitation).
Intervention
The intervention followed the ‘Remembering Yesterday, Caring Today’ (RYCT) manual [13],
developed in the trial platform for this study [14]. Joint reminiscence groups emphasise active
and passive reminiscence by both carers and people with dementia. Group sessions were held
weekly over 12 consecutive weeks, followed by seven monthly maintenance group sessions.
Sessions were led by two trained facilitators in each centre, supported by trained volunteers.
The manual recommends a blend of activities for each session, based on core principles. Each
session lasted two hours and focused on a different theme, including childhood, schooldays,
working life, marriage, and holidays and journeys. Dyads were encouraged to contribute with
materials brought from home. Maintenance sessions followed a similar pattern. Each session
blended work in large and small groups, and a range of activities including art, cooking, physi-
cal re-enactment of memories, singing and oral reminiscence. Since inclusion of the person
with dementia was considered paramount, facilitators and volunteers guided carers to value
their contribution by allowing the person with dementia to actively participate. Fidelity of the
intervention was assured through regular meetings of the treatment facilitators with the trainer,
and by the completion of an adherence checklist at the end of each group session.
Usual care (treatment as usual—TAU)
The services and interventions available to people with dementia and family carers randomised
to receive usual treatment varied between and within centres and over time. Both this group
and the treatment group could access any other services, except when the reminiscence groups
were scheduled at the same time as an alternative activity.
Ethical arrangements
No harmful side-effects from participating in reminiscence groups have been documented [7].
Participants entered the study only after giving written informed consent in accordance with
the provisions of the Mental Capacity Act 2005. In the event of a participant being judged to
lose capacity to consent to participate during the trial, the views of a personal consultee (the
carer) were sought regarding continuation. At any point where a participant with dementia
became distressed by the assessments they were discontinued. Informed consent was sought
separately from the family carer for their own participation.
Outcome measures
Primary and secondary measures were completed at baseline, three months after baseline (first
follow-up) and ten months after baseline (second follow-up and primary end-point). For the
first follow-up the interviews were conducted after the completion of the weekly reminiscence
sessions, and for the second follow-up they were after the final monthly maintenance session.
Primary outcome measures. a) Quality of life of the person with dementia, using the scale
Quality of Life in Alzheimer’s Disease (QoL-AD), which covers 13 domains of quality of life
[15,16]. For this measure, up to two missing values may be replaced with the mean of the other
scores. Scores range from 13 to 52; higher scores indicate better quality of life.
b) Carer’s mental health, assessed using the 28-item, self-completed General Health Ques-
tionnaire GHQ-28 [17] which has been widely used in care-giver research [18,19] and
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comprises 4 sub-scales: anxiety/insomnia, depression, social dysfunction and somatic symp-
toms. Higher scores indicate worse mental health, ranging from 0 to 84.
Secondary outcome measures. a) Autobiographical memory, assessed using an extended
version of the Autobiographical Memory Interview (AMI) [20] assessing recall of personal
memories with sub-scales for both factual (semantic) information (e.g. names of schools or
teachers) and specific incidents. The scores range from 0 to 108 for semantic subscale and 0 to
39 for incidents. Higher scores indicate better memory.
b) Quality of relationship, assessed separately by both person with dementia and carer using
the Quality of the Carer–Patient Relationship (QCPR) [21] comprising 14 items rated on
5-point Likert scales, with two sub-scales designed to assess the warmth of the relationship and
the absence of conflict and criticism. Scores range from 14–70 with higher scores reflecting bet-
ter relationships.
c) Depression and anxiety, using the Cornell Scale for Depression in Dementia (CSDD) [22]
and the Rating Anxiety In Dementia (RAID) [23] for the person with dementia. The CSDD (19
items) and the RAID (18 items) are based on interviews with the people with dementia and
their carers. The CSDD scores range from 0 to 38 with higher scores reflecting a higher level of
depression. The Hospital Anxiety and Depression Scale (HADS) [24] (used for carers) is a well-
validated 14-item, self-completed scale with sub-scales for anxiety and depression suitable for
use with adults of all ages. For each HADS sub-scale, a single missing value may be replaced
with the mean of the other scores from that sub-scale. Each subscale is scored on a 0 to 21
range with higher scores indicating elevated levels of anxiety or depression.
d) Stress specific to care-giving, using the Relative's Stress Scale [25], which asks the care-
giver to complete 15 5-point Likert items. Scores range is 0 to 60 with higher scores indicating
a higher level of stress.
e) Quality of life of person with dementia, rated by the care-giver using the proxy version of
the QoL-AD [15], identical in structure and content to the version completed by the person
with dementia. Scores range from 13 to 52 with higher scores indicating a better perceived
quality of life.
f) General quality of life of both care-giver and person with dementia, used the 5 item EQ-
5D-3L and associated visual analogue scale EQ VAS [26]. Carers completed the measure from
their own perspective and for the person with dementia, who would also complete it whenever
possible.
g) Functional ability of person with dementia, using the Bristol Activities of Daily Living
Scale [27], a 20-item scale completed by the carer. Scores range from 0 to 60 with a higher
score reflecting more dependency.
h) Use of health, social care and voluntary services by the person with dementia and their
carer was recorded using an adapted Client Services Receipt Inventory (CSRI) [28].
Micro-costing of reminiscence group therapy and maintenance
Amicro-costing of the RYCT intervention was undertaken by recording the types and quanti-
ties of resource input including: staff time, materials, room rental, training and supervision of
staff. Information was provided by the principal investigators for each site, who oversaw the
resources available for the intervention and by group facilitators in relation to staff time utilisa-
tion, materials and other resources used. Unit costs, tariffs or prices were then assigned for
each item as appropriate, with actual costs used for items such as transport, venue hire and
freelance facilitator and trainer fees. Appropriate national salary scales were used for staff who
were NHS or University employees, including national insurance and pension costs, but not
organisational overheads or high-cost area supplements. The costs for each RYCT programme
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of 12 weekly and 7 maintenance sessions for which complete data were available were calcu-
lated, and the mean cost per programme and for each expenditure category was then derived.
The cost per dyad was then calculated by dividing the cost per programme by the number of
dyads randomised to the programmes for which the costing information was available.
Analysis
The trial was initially powered to detect a standardised difference of 0.38 in the QoL-AD rated
by the person with dementia and 0.28 in the General Health Questionnaire-28 or carer-rated
QoL-AD, requiring 200 dyads in each arm to complete the 10 month assessment. This allowed
for clustering effects within groups, using an intraclass correlation coefficient (ICC) of 0.1.
With predicted attrition of 30% the initial target sample size was 576 dyads. During the trial
this target was revised in the light of lower clustering effects (ICC calculated at 0.02) and better
retention rates. Assuming 72% retention, the revised recruitment target of 508 provided a
potential sample of 366 at 10 month follow-up. This provided 80% power to detect a standard-
ised difference of 0.30 in the primary outcome measures at the 5% significance level. Intention
to treat analysis was used primarily. Multiple imputation methods were used to estimate miss-
ing outcome measure scores at a time point, using a linear regression model accounting for
age, gender, spousal care, centre, wave and other outcome scores. At follow up time points the
treatment group allocation was also included in the model. For baseline, one imputation was
used due to the small amount of missing outcomes; at follow up time points five imputations
were used. The number of imputations used reflected the percentage of missing data present in
the dataset [29]. The primary model fitted was an ANCOVA using 10-month outcome as the
dependent variable, baseline score on the outcome measure and the age of the person with
dementia as covariates, treatment allocation, gender of the person with dementia, spousal
(spouse/other) as fixed factors and location and wave as random factors, with the interaction
between location and allocation also being taken into account. Carer age and gender were also
added for carer and proxy outcomes.
Secondary analyses included analysis of the secondary outcomes at the 10 month point and
also fitted all the models using the 3-month outcome as the dependent variable. A further com-
pliance analysis was also undertaken including a variable denoting the number of sessions that
participants assigned to the intervention arm had actually participated in. SPSS PASW (version
18) was used for the analyses.
Economic Analyses
Cost-effectiveness analysis. The economic analysis takes a multi-sectoral public sector
perspective spanning the NHS (dementia services, primary and secondary care) and local gov-
ernment. Cost-effectiveness was evaluated in terms of the primary outcome for the person with
dementia (the disease specific QoL-AD) at the primary end-point, on an intention to treat
basis, using only cases with full cost data. Missing QoL-AD values were imputed as described
previously. The incremental cost effectiveness ratio (ICER) was calculated as the ratio of the
difference in costs to the difference in outcomes between the intervention and control groups.
This incremental cost effectiveness ratio point estimate reflects the mean cost of a one point
change on the scale reflecting an improvement in quality of life. Non-parametric bootstrapping
(5,000 replications) was used to address the uncertainty associated with point estimates of costs
and outcomes, providing a confidence interval for the ICER. It was planned to produce cost
effectiveness acceptability curves to provide probabilistic analysis for a range of cost effective-
ness ceilings for policy makers.
Reminiscence Groups and Dementia
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Secondary Cost-Utility Analysis. A cost utility analysis was conducted, calculating costs
per quality adjusted life year (QALY), with QALYs derived from the EQ-5D. The area under
the curve method was used to generate total QALYs. Two analyses were carried out; the first
using the EQ-5D as completed by the person with dementia and the second the self-report EQ-
5D completed by their carers. Only cases with full cost data were included, but missing EQ-5D
values were imputed as described above. It was planned to produce cost effectiveness accept-
ability curves with non-parametric bootstrapping using 5000 replications so that the probabil-
ity of the intervention meeting a range of cost per QALY thresholds could be estimated.
Results
Demographic and follow up information
Across the study sites, 2908 potential participants were considered for inclusion, either through
identification by screening of clinical notes or by referral from clinical teams or other services.
Table 1 indicates the reasons for losses between referral / screening and randomization. The
major reasons were related to it not proving possible to contact the person or carer or to the
application of the inclusion/exclusion criteria. Of those contacted, eligible and available 36%
agreed to take part. The final sample size of 350 dyads completing the 10 month end-point
assessment represented 95% of the revised target sample size, with an overall attrition rate of
28%, or 22% excluding deaths (Fig 1). Of the people with dementia, 242 (50%) were female,
447 (95%) were of white ethnicity, 337 (72%) were married and mean age was 77.5 (sd 7.3).
The carers comprised 325 (67%) females, 448 (96%) of white ethnicity, 345 (74%) were caring
for their spouse and mean age was 69.7 (sd 11.6). Table 2 indicates that the people with demen-
tia and carers in the two groups were well matched at baseline for clinical and demographic
characteristics. Attrition was higher in the control group at 10 months (34% control v. 24%
Table 1. Reasons for losses between referral and randomisation.
Reason Total (%)
Total referred or screened 2908
Unable to ﬁnd Memory Clinic record 115 (5)
Could not make contact by telephone 393 (16)
Does not wish to take part 863 (36)
Does not meet clinical criteria 108 (4)
No suitable carer 69 (3)
Now in residential care 95 (4)
Already participating in a similar study 14 (<1)
Exclusion criteria apply 91 (4)
Unable to attend on the day that joint reminiscence groups are being held 113 (5)
Other
Family situation at the time 41 (2)
Carer or participant died 96 (4)
Health issues for participant or carer 168 (7)
Participant unaware of dementia diagnosis 5 (<1)
Not available 209 (9)
Does not like groups—reference to dislike of intervention 17 (<1)
Unknown 23 (1)
Total lost between referral/screening and randomisation 2420
Total number randomised 488
Conversion rate 17%
doi:10.1371/journal.pone.0152843.t001
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intervention) with those lost from the control group having a lower level of dementia severity.
No serious adverse events related to the trial were recorded.
Primary and secondary outcomes
The GHQ-28 was the only outcome measure showing deviation from a normal distribution
and accordingly was subject to a natural log-transformation. The intention to treat analyses
indicated there were no differences in outcome between the intervention and control condi-
tions on primary outcomes at the ten-month end point (self-reported QoL-AD mean differ-
ence 0.07, s.e. 0.65;, p = 0.53; GHQ 28 mean difference 0.09, s.e. 0.06;, p = 0.35: Tables 3 and 4).
There were also no differences on the primary outcomes at the three-month end point (self-
reported QoL-AD mean difference -0.76, s.e. 0.59;, p = 0.63 (Table 3), GHQmean difference
0.02, s.e. 0.05 p = 0.86 (Table 4)).
There were no significant differences on secondary outcome measures, at either ten or
three-month end points, apart from the finding that carers of people with dementia allocated
to the reminiscence intervention had significantly increased anxiety on the General Health
Questionnaire-28 sub-scale at the ten month end-point (mean difference 1.25, s.e. 0.5;,
p = 0.04, 5 of the 5 multiple imputations also significant). There was no evidence of this differ-
ence at the 3 month time point.
Compliance analysis
Taking attendance at six or more of the twelve weekly sessions as an index of compliance, on
the basis of clinical consensus, 70% of those allocated to the intervention received it as planned.
Table 2. Baseline characteristics of people with dementia and carers—mean (sd).
People with dementia Possible range of scores Intervention (n = 268) Control (n = 219)
Age - 77.5 (7.3) 77.3 (7.2)
Female = 47% 52%
Married = 72% 72%
Spousal relationship = 70% 72%
Quality of Life in Alzheimer’s Disease (QoL-AD) (self rating) 13–52 37.5 (5.3) 37.0 (5.4)
Quality of Life in Alzheimer’s Disease (QoL-AD) (proxy rating) 13–52 31.5 (6.3) 31.5 (6.5)
Autobiographical Memory Interview—semantic (AMIF) 0–108 56.1 (23.0) 54.3 (24.2)
Autobiographical Memory Interview—incidents (AMIM) 0–39 12.5 (6.9) 12.9 (7.8)
Quality of Carer Patient Relationship (QCPR) 14–70 57.8 (6.4) 57.5 (6.1)
Bristol Activities of Daily Living Scale (BADLS) 0–60 16.6 (9.4) 15.1 (9.8)
Rating of Anxiety in Dementia (RAID) 0–54 8.8 (7.5) 8.2 (6.6)
Cornell Scale for Depression in Dementia (CSDD) 0–38 7.0 (4.9) 6.9 (5.1)
Carers Intervention (n = 268) Control (n = 219)
Age - 69.6 (11.6) 69.7 (11.6)
Female - 70% 63%
Married - 87% 82%
General Health Questionnaire (GHQ28) 0–84 22.8 (11.7) 23.1 (12.0)
Hospital Anxiety & Depression Scale (HADS) Anxiety 0–21 6.4 (4.3) 6.0 (4.2)
Hospital Anxiety & Depression Scale (HADS) Depression 0–21 4.3 (3.5) 4.1 (3.4)
European Quality of Life 5 Dimensions Visual Analogue Scale (EQ-5D VAS) 0–100 74.3 (17.8) 72.9 (19.7)
Relatives Stress Scale (RSS) 0–60 21.8 (10.9) 21.3 (10.9)
Quality of Carer Patient Relationship (QCPR) 14–70 53.5 (8.8) 53.6 (8.6)
doi:10.1371/journal.pone.0152843.t002
Reminiscence Groups and Dementia
PLOS ONE | DOI:10.1371/journal.pone.0152843 April 19, 2016 9 / 19
T
ab
le
3.
P
ri
m
ar
y
an
d
se
co
n
d
ar
y
en
d
p
o
in
tr
es
u
lt
s
ad
ju
st
ed
an
al
ys
is
m
o
d
el
s
fo
r
p
er
so
n
w
it
h
d
em
en
ti
a
m
ea
su
re
s.
A
d
ju
st
ed
fo
r
p
ar
ti
ci
p
an
ta
g
e,
b
as
el
in
e
o
u
tc
o
m
e
sc
o
re
,c
en
-
tr
e,
p
ar
ti
ci
p
an
tg
en
d
er
,r
el
at
io
n
sh
ip
(s
p
o
u
sa
l/n
o
n
-s
p
o
u
sa
l).
M
ea
su
re
D
at
a
P
ri
m
ar
y
en
d
p
o
in
t
(1
0
m
o
n
th
fo
llo
w
u
p
)
S
ec
o
n
d
ar
y
en
d
p
o
in
t
(3
m
o
n
th
fo
llo
w
u
p
)
M
is
si
n
g
(N
=
35
0)
T
re
at
m
en
t
M
ea
n
C
o
n
tr
o
l
M
ea
n
G
ro
u
p
d
if
fe
re
n
ce
M
ea
n
95
%
C
I
o
f
M
D
P va
lu
e
E
ff
ec
t
S
iz
e
M
is
si
n
g
(N
=
39
5)
T
re
at
m
en
t
M
ea
n
C
o
n
tr
o
l
M
ea
n
G
ro
u
p
D
iff
er
en
ce
M
ea
n
95
%
C
I
o
f
M
D
P va
lu
e
E
ff
ec
t
S
iz
e
Q
oL
-A
D
(s
el
f)
C
om
pl
et
e
ca
se
46
36
.8
6
36
.7
9
0.
07
(-
1.
20
,
1.
34
)
0.
53
0.
01
34
36
.8
8
37
.6
4
-0
.7
6
(-
1.
92
,
0.
4)
0.
63
0.
07
Q
oL
-A
D
(s
el
f)
Im
pu
te
d
da
ta
0
36
.7
5
36
.4
7
0.
29
(-
1.
10
,
1.
68
)
0.
68
0.
02
0
36
.7
6
36
.9
7
-0
.6
4
(-
1.
82
,
0.
54
)
0.
29
0.
06
Q
oL
-A
D
(p
ro
xy
)
C
om
pl
et
e
ca
se
11
31
.2
31
.7
-0
.5
(-
1.
72
,
0.
72
)
0.
2
0.
04
32
30
.9
8
31
.8
1
-0
.8
4
(-
1.
9,
0.
22
)
0.
46
0.
09
Q
oL
-A
D
(p
ro
xy
)
Im
pu
te
d
da
ta
0
31
.2
2
31
.4
6
-0
.2
4
(-
1.
30
,
0.
82
)
0.
66
0.
02
0
30
.8
8
31
.5
4
-0
.7
(-
1.
74
,
0.
34
)
0.
18
0.
07
A
M
IF
C
om
pl
et
e
ca
se
22
49
.7
5
49
.1
8
0.
58
(-
3.
32
,
4.
48
)
0.
85
0.
02
9
52
.1
8
49
.8
4
2.
34
(-
0.
95
,
5.
63
)
0.
14
0.
08
A
M
IF
Im
pu
te
d
da
ta
0
46
.1
9
47
.9
8
-1
.7
9
(-
5.
55
,
1.
97
)
0.
35
0.
05
0
51
.6
1
50
.1
6
1.
45
(-
1.
29
,
4.
19
)
0.
3
0.
06
A
M
IM
C
om
pl
et
e
ca
se
22
12
.5
6
12
.2
4
0.
16
(-
1.
39
,
1.
71
)
0.
49
0.
01
9
11
.3
1
11
.2
4
0.
59
(-
0.
8,
1.
98
)
0.
24
0.
05
A
M
IM
Im
pu
te
d
da
ta
0
12
.4
12
.6
1
-0
.3
6
(-
1.
71
,
0.
99
)
0.
6
0.
03
0
10
.7
2
11
.0
7
0.
17
(-
0.
95
,
1.
29
)
0.
77
0.
02
Q
C
P
R
(p
at
ie
nt
)
C
om
pl
et
e
ca
se
52
57
.6
6
56
.9
9
0.
67
(-
1.
00
,
2.
34
)
0.
65
0.
05
48
57
.3
2
56
.8
4
0.
48
(-
1.
46
,
2.
42
)
0.
84
0.
03
Q
C
P
R
(p
at
ie
nt
)
Im
pu
te
d
da
ta
0
57
.3
7
56
.7
4
0.
64
(-
0.
77
,
2.
05
)
0.
37
0.
05
0
56
.8
3
56
.5
2
0.
31
(-
1.
12
,
1.
74
)
0.
67
0.
02
B
A
D
LS
C
om
pl
et
e
ca
se
10
18
.2
2
18
.9
6
-0
.7
4
(-
2.
50
,
1.
02
)
0.
2
0.
04
28
17
.1
7
16
.6
5
0.
52
(-
0.
83
,
1.
87
)
0.
42
0.
04
B
A
D
LS
Im
pu
te
d
da
ta
0
18
.7
7
19
.9
-1
.1
3
(-
2.
50
,
0.
24
)
0.
11
0.
09
0
17
.3
2
16
.8
4
0.
48
(-
0.
83
,
1.
79
)
0.
47
0.
04
R
A
ID
C
om
pl
et
e
ca
se
47
7.
61
7.
3
0.
32
(-
1.
29
,
1.
93
)
0.
58
0.
02
74
8.
5
7.
28
1.
22
(-
0.
37
,
2.
81
)
0.
22
0.
09
R
A
ID
Im
pu
te
d
da
ta
0
8.
18
7.
74
0.
44
(-
0.
99
,
1.
87
)
0.
54
0.
03
0
8.
69
8.
03
0.
66
(-
0.
56
,
1.
88
)
0.
29
0.
06
C
S
D
D
C
om
pl
et
e
ca
se
69
6.
83
6.
71
0.
12
(-
1.
19
,
1.
43
)
0.
71
0.
01
68
7.
54
7.
52
0.
02
(-
1.
27
,
1.
31
)
0.
36
0.
00
C
S
D
D
Im
pu
te
d
da
ta
0
7.
31
6.
94
0.
38
(-
0.
68
,
1.
44
)
0.
48
0.
04
0
7.
78
8.
07
-0
.2
9
(-
1.
47
,
0.
89
)
0.
63
0.
03
E
Q
-5
D
C
om
pl
et
e
ca
se
39
0.
80
4
0.
80
6
-0
.0
01
(-
0.
06
,
0.
06
)
0.
72
0.
00
48
0.
76
4
0.
75
6
0.
00
8
(-
0.
04
,
0.
06
)
0.
95
0.
02
E
Q
-5
D
Im
pu
te
d
da
ta
0
0.
77
2
0.
76
9
0.
00
4
(-
0.
05
,
0.
06
)
0.
88
0.
01
0
0.
75
0.
73
6
0.
01
4
(-
0.
03
,
0.
06
)
0.
54
0.
03
E
Q
-5
D
V
A
S
C
om
pl
et
e
ca
se
41
70
.5
5
70
.9
6
-0
.4
1
(-
4.
98
,
4.
16
)
0.
98
0.
01
26
72
.9
7
72
.5
4
0.
43
(-
4.
22
,
5.
08
)
0.
48
0.
01
E
Q
-5
D
V
A
S
Im
pu
te
d
da
ta
0
70
.6
4
70
.3
7
0.
27
(-
3.
61
,
4.
15
)
0.
89
0.
01
0
72
.3
1
71
.5
2
0.
79
(-
3.
05
,
4.
63
)
0.
69
0.
02
(C
on
tin
ue
d
)
Reminiscence Groups and Dementia
PLOS ONE | DOI:10.1371/journal.pone.0152843 April 19, 2016 10 / 19
T
ab
le
3.
(C
on
tin
ue
d
)
M
ea
su
re
D
at
a
P
ri
m
ar
y
en
d
p
o
in
t
(1
0
m
o
n
th
fo
llo
w
u
p
)
S
ec
o
n
d
ar
y
en
d
p
o
in
t
(3
m
o
n
th
fo
llo
w
u
p
)
M
is
si
n
g
(N
=
35
0)
T
re
at
m
en
t
M
ea
n
C
o
n
tr
o
l
M
ea
n
G
ro
u
p
d
if
fe
re
n
ce
M
ea
n
95
%
C
I
o
f
M
D
P va
lu
e
E
ff
ec
t
S
iz
e
M
is
si
n
g
(N
=
39
5)
T
re
at
m
en
t
M
ea
n
C
o
n
tr
o
l
M
ea
n
G
ro
u
p
D
iff
er
en
ce
M
ea
n
95
%
C
I
o
f
M
D
P va
lu
e
E
ff
ec
t
S
iz
e
E
Q
-5
D
(p
ro
xy
)
C
om
pl
et
e
ca
se
17
0.
58
8
0.
62
6
-0
.0
38
(-
0.
10
,
0.
03
)
0.
37
0.
06
32
0.
59
4
0.
57
5
0.
01
8
(-
0.
04
,
0.
07
)
0.
81
0.
04
E
Q
-5
D
(p
ro
xy
)
Im
pu
te
d
da
ta
0
0.
57
5
0.
59
6
-0
.0
21
(-
0.
07
,
0.
03
)
0.
44
0.
04
0
0.
58
4
0.
56
0.
02
4
(-
0.
03
,
0.
07
)
0.
36
0.
05
E
Q
-5
D
V
A
S
(p
ro
xy
)
C
om
pl
et
e
ca
se
12
62
.1
63
.2
-1
.1
1
(-
5.
44
,
3.
22
)
0.
59
0.
03
29
57
.1
2
59
.5
8
-2
.4
6
(-
6.
58
,
1.
66
)
0.
67
0.
07
E
Q
-5
D
V
A
S
(p
ro
xy
)
Im
pu
te
d
da
ta
0
60
.5
5
62
.4
3
-1
.8
8
(-
5.
66
,
1.
9)
0.
33
0.
05
0
56
.4
8
58
.9
7
-2
.4
9
(-
6.
08
,
1.
1)
0.
17
0.
07
do
i:1
0.
13
71
/jo
ur
na
l.p
on
e.
01
52
84
3.
t0
03
Reminiscence Groups and Dementia
PLOS ONE | DOI:10.1371/journal.pone.0152843 April 19, 2016 11 / 19
T
ab
le
4.
P
ri
m
ar
y
an
d
se
co
n
d
ar
y
en
d
p
o
in
tr
es
u
lts
ad
ju
st
ed
an
al
ys
is
m
o
d
el
s
fo
r
ca
re
r
m
ea
su
re
s.
A
d
ju
st
ed
fo
r
ca
re
r
ag
e,
b
as
el
in
e
o
u
tc
o
m
e
sc
o
re
,c
en
tr
e,
ca
re
r
g
en
d
er
,r
el
a-
ti
o
n
sh
ip
(s
p
o
u
sa
l/n
o
n
-s
p
o
u
sa
l).
M
ea
su
re
D
at
a
P
ri
m
ar
y
en
d
p
o
in
t
(1
0
m
o
n
th
fo
llo
w
u
p
)
S
ec
o
n
d
ar
y
en
d
p
o
in
t
(3
m
o
n
th
fo
llo
w
u
p
)
M
is
si
n
g
(n
=
35
0)
T
re
at
m
en
t
M
ea
n
C
o
n
tr
o
l
M
ea
n
G
ro
u
p
d
if
fe
re
n
ce
M
ea
n
95
%
C
I
o
f
M
D
P va
lu
es
E
ff
ec
t
S
iz
e
M
is
si
n
g
(N
=
39
5)
T
re
at
m
en
t
M
ea
n
C
o
n
tr
o
l
M
ea
n
G
ro
u
p
D
iff
er
en
ce
M
ea
n
95
%
C
I
o
f
M
D
P va
lu
es
E
ff
ec
t
S
iz
e
G
H
Q
28
(lo
g
tr
an
sf
or
m
)
C
om
pl
et
e
ca
se
31
3.
06
2.
97
0.
09
(-
0.
03
,
0.
21
)
0.
35
0.
08
38
2.
99
2.
97
0.
02
(-
0.
08
,
0.
12
)
0.
86
0.
02
G
H
Q
28
(lo
g
tr
an
sf
or
m
)
Im
pu
te
d
da
ta
0
3.
08
3.
01
0.
07
(-
0.
05
,
0.
19
)
0.
24
0.
06
0
3.
01
2.
99
0.
02
(-
0.
1,
0.
14
)
0.
74
0.
02
H
A
D
S
A
nx
ie
ty
C
om
pl
et
e
ca
se
9
6.
48
5.
47
1
(0
.1
,
1.
9)
0.
15
0.
12
28
5.
98
5.
64
0.
35
(-
0.
39
,
1.
09
)
0.
61
0.
05
H
A
D
S
A
nx
ie
ty
Im
pu
te
d
da
ta
0
6.
58
5.
99
0.
59
(-
0.
19
,
1.
37
)
0.
14
0.
08
0
6.
15
5.
96
0.
18
(-
0.
43
,
0.
79
)
0.
56
0.
03
H
A
D
S
D
ep
re
ss
io
n
C
om
pl
et
e
ca
se
9
4.
77
4.
53
0.
25
(-
0.
51
,
1.
01
)
0.
58
0.
03
28
4.
53
4.
42
0.
11
(-
0.
5,
0.
72
)
0.
83
0.
02
H
A
D
S
D
ep
re
ss
io
n
Im
pu
te
d
da
ta
0
5.
12
5.
03
0.
09
(-
0.
64
,
0.
82
)
0.
81
0.
01
0
4.
69
4.
76
-0
.0
8
(-
0.
63
,
0.
47
)
0.
78
0.
01
R
S
S
C
om
pl
et
e
ca
se
14
22
.0
3
21
.5
5
0.
48
(-
1.
64
,
2.
6)
0.
95
0.
02
31
22
.9
6
21
.9
9
0.
98
(-
0.
76
,
2.
72
)
0.
21
0.
06
R
S
S
Im
pu
te
d
da
ta
0
22
.9
3
22
.8
7
0.
06
(-
1.
86
,
1.
98
)
0.
95
0.
00
0
23
.2
2
22
.4
8
0.
75
(-
0.
84
,
2.
34
)
0.
36
0.
05
Q
C
P
R
(c
ar
er
)
C
om
pl
et
e
ca
se
17
53
.1
3
53
.0
6
0.
07
(-
1.
89
,
2.
03
)
0.
45
0.
00
43
51
.6
1
53
.1
-1
.4
9
(-
3.
1,
0.
12
)
0.
24
0.
10
Q
C
P
R
(c
ar
er
)
Im
pu
te
d
da
ta
0
52
.1
3
51
.5
7
0.
55
(-
1.
17
,
2.
27
)
0.
53
0.
03
0
51
.3
9
52
.5
7
-1
.1
8
(-
2.
71
,
0.
35
)
0.
13
0.
08
E
Q
-5
D
C
om
pl
et
e
ca
se
12
0.
73
3
0.
79
6
-0
.0
64
(-
0.
12
,
0)
0.
11
0.
11
31
0.
78
2
0.
77
2
0.
01
(-
0.
03
,
0.
05
)
0.
77
0.
02
E
Q
-5
D
Im
pu
te
d
da
ta
0
0.
71
3
0.
75
8
-0
.0
44
(-
0.
09
,
0.
01
)
0.
09
0.
09
0
0.
77
6
0.
76
1
0.
01
4
(-
0.
02
,
0.
05
)
0.
44
0.
04
E
Q
-5
D
V
A
S
C
om
pl
et
e
ca
se
10
72
.6
8
71
.7
2
0.
97
(-
3.
4,
5.
34
)
0.
82
0.
02
24
72
.4
73
.3
6
-0
.9
6
(-
5.
04
,
3.
12
)
0.
64
0.
02
E
Q
-5
D
V
A
S
Im
pu
te
d
da
ta
0
70
.4
7
69
.4
4
1.
03
(-
2.
69
,
4.
75
)
0.
58
0.
03
0
71
.5
4
71
.4
8
0.
07
(-
3.
44
,
3.
58
)
0.
97
0.
00
do
i:1
0.
13
71
/jo
ur
na
l.p
on
e.
01
52
84
3.
t0
04
Reminiscence Groups and Dementia
PLOS ONE | DOI:10.1371/journal.pone.0152843 April 19, 2016 12 / 19
This fell to 57% when considering those dyads who additionally attended 3 or more of the
monthly maintenance sessions. The number of weekly sessions attended was associated with
improved performance on the Autobiographical Memory Interview (Memory) scale at the
three month time-point (p = .023).
For the person with dementia, there was some evidence that improvement in the ten month
score on the Quality of the Carer-Patient Relationship scale was associated with the number of
monthly sessions attended (p = .043, 1 of 5 multiple imputations significant). This effect
applied to the QCPR warmth sub-scale, but not the absence of criticism sub-scale. Number of
sessions attended was also linked to a significant improvement in self-reported quality of life
(EQ-5D utility) at ten months for people with dementia in the intervention group (p = .012
with three out of five multiple imputations significant).
However, carers showed increased stress related to caregiving associated with more sessions
attended. At 10 months the number of sessions attended was associated with worse scores on
the Relatives‘ Stress Scale (, p = .005 with four out of five multiple imputations significant). In
the intervention arm, carers who continued to attend the reminiscence groups regularly scored
23.36 (se 1.33) but those who did not attend the groups or attended infrequently scored only
18.70 (se 1.77). Carers in the control arm scored 21.57 (se 1.19).
Economic Analyses
Micro-costing of reminiscence group therapy and maintenance. Table 5 summarises the
direct costs for 19 of the 28 RYCT programmes that ran over the course of the trial. For nine
Table 5. Base case costs for Remembering Yesterday Caring Today (RYCT) programme of 12 weekly joint reminiscence groups and 7monthly
maintenance sessions based on data from 19 waves of recruitment.
na Mean cost for the provision of each
19 session programme (£)
sd Minimum
(£)
Maximum
(£)
Mean cost per session for 19
session programme (£)
Training relatedb 19 299 242 0 797 16
Group facilitatorsc, d 19 4,931 1,531 2,795 7,511 260
Supporting staff (salary)d, e 19 906 1,028 0 3,163 48
Travel costs (facilitators
and staff)
19 266 461 0 1,900 14
Sub-total (staff related) 6,402 338
Venue 19 378 486 0 1,846 20
Participant and carer
transport
19 2,258 1,583 100 4,750 119
Reminiscence materials,
resources, etc.
19 158 114 0 330 8
Refreshments 19 185 38 95 237 10
Administration 19 52 35 0 102 3
Totals 9,433 498
a. Number of recruitment waves for which data were available.
b. Includes fees for reminiscence consultant and, where applicable, venue hire, salaries, freelancer fees, travel and subsistence.
c. Facilitators comprised of both freelancers and NHS or university employees.
d. Salary costs based on NHS Agenda for Change pay scales 2010/2011 and Bangor University Pay Scales 2010. To preserve privacy, salaries were
calculated using the spine point nearest to the middle of the relevant scale.
e. Costs calculated for supporting staff in NHS or university employment whose normal duties included activities connected to the running of the sessions
(some paid assistants together with administrative and clinical support). Assistants who were NHS or local authority employees released from their normal
duties to gain additional experience and skills were not costed.
doi:10.1371/journal.pone.0152843.t005
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programmes cost data were either incomplete or unavailable (not collected). The cost per 19
session programme ranged from £4,215 to £14,579 with a mean cost of £9,433 (sd £2,651).
Approximately two-thirds of the mean total cost of running a programme was accounted for
by staff related costs, of which the largest sub-category was for group facilitators. Differences in
employment arrangements for staff (freelance, with a fixed fee per session v. employed staff
with additional employment costs) accounted for much of the variation between centres. The
second highest costs related to transport for participants with dementia and their carers, vary-
ing considerably between programmes as transport had to be tailored to individual circum-
stances. The costing of reminiscence materials and resources was problematic. Costs presented
in this category reflect the direct costs incurred by programmes in purchasing materials and
resources and do not include any attempt at costing items brought to sessions by individuals/
organisations, or recycled from previous sessions. The mean cost per dyad for the provision of
a 19 session Remembering Yesterday Caring Today programme was £964 (based on a mean of
9.79 dyads per programme).
Cost of service use. The costs of service use are derived from using national unit costs [30,
31]. Unit costs for each health and social care service were multiplied by the frequencies
recorded in the Client Service Receipt Inventory completed by participants with dementia and
carers. The analysis has been restricted to cases where full cost data could be calculated (i.e.
where health and social care service use data had been obtained at both 3 and 10 month follow-
ups). The price year used was 2010. Given that follow up was for less than 12 months discount-
ing was not applied to either costs or outcomes.
Table 6 summarises the mean total costs of health and social care service use for the inter-
vention and control groups for participants with dementia and carers over 10 months. While
the mean total costs for participants with dementia in the intervention group were 13.5%
(£580) higher overall than for the control group, this was not statistically significant. Most of
the difference is accounted for by the higher mean cost of day care for the intervention group,
which is 80% higher than the mean cost for the control group. This higher mean cost reflected
the increased frequency of day service use (though not statistically significant overall) for par-
ticipants with dementia in the intervention group. For carers, mean costs for the intervention
Table 6. Summary of health and social service costs to the intervention and control groups over 10 months.
Service Reminiscence (n = 196) Mean
total costs (£)
SD Control (n = 140) Mean
total costs (£)
SD Difference in mean total
costs (£)
Asympt
Siga
Participants with
dementia
Community care 1,072 1,809 1,170 1,983 -98 0.674
Day care 1,098 4,451 610 1,415 488 0.230
Hospital use 2,719 7,106 2,529 8,087 190 0.801
Total (participant with
dementia)
4,889 8,806 4,309 8,729 580 0.471
Carers
Community care 258 339 283 449 -25 0.505
Day care 7 77 34 307 -27 0.400
Hospital use 1,266 3,752 1,043 3,622 223 0.694
Total (carer) 1,531 4,647 1,360 1,459 171 0.800
Grand total 6,419 5,667 751
a: Asymptotic signiﬁcances for Mann-Whitney U Test
doi:10.1371/journal.pone.0152843.t006
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group were 12.7% higher overall than the control group over the 10 month period (£171),
although again this was not statistically significant.
Cost-effectiveness analysis. The incremental cost-effectiveness for the QoL-AD was
£2,586 (i.e. the mean cost of a one point change on the scale reflecting an improvement in qual-
ity of life) (Table 7). It should be noted that the 95% confidence intervals for this estimate were
extremely broad, and as they include zero, the ratio is not statistically significant. In view of the
lack of clinical effectiveness, and the higher costs associated with the intervention group, the
generation of cost-effectiveness acceptability curves was not appropriate.
Cost-utility analysis. Cost-utility analysis was undertaken separately for participants with
dementia and their carers using the total cost of health and social care services and QALYs gen-
erated from the self-completed EQ-5D. Cases included all those for whom complete cost data
were available (n = 336).
While a full cost-utility analysis had been planned as part of the economic evaluation of the
REMCARE trial, the results showed that generating cost-effectiveness acceptability curves
would not be meaningful. The mean costs of health and social care service use were higher for
the intervention group (Table 6) and the costs of the joint reminiscence and maintenance ses-
sions only applied to the intervention arm, giving a higher overall mean cost for the interven-
tion group compared to the control group. Coupled with the lack of any statistically significant
effect from the self-reported EQ-5D, this indicated that the intervention could not be cost-
effective. Results shown in Table 8 confirm that the mean difference in QALYs between inter-
vention and control arms for both participants with dementia and carers were negligible.
Given that these would generate meaninglessly high incremental cost per QALY figures, they
have not been calculated.
Discussion
This trial does not provide support for the effectiveness of joint reminiscence groups for people
with dementia and their carers in relation to intention to treat analyses of primary or secondary
Table 7. Summary of results of the cost-effectiveness analysis for participants with dementia using
QoL-AD as a measure of effectiveness.
Intervention
(n = 196)
Control
(n = 140)
Difference
Mean total cost in £ (SD) 5853 (8806) 4309 (8729) 1544
Mean QoL-AD score (SD) 37.013 (4.768) 36.416 (4.692) 0.597
Incremental Cost-Effectiveness Ratio (£)
(95% CI)
2586 (-20280;
24340)
doi:10.1371/journal.pone.0152843.t007
Table 8. Summary of results of the cost-utility analysis.
Person with dementia Carer
Reminiscence
(n = 196)
Control
(n = 140)
Difference Reminiscence
(n = 196)
Control
(n = 140)
Difference
Mean total
cost in £
(SD)
5853 (8806) 4309
(8729)
1544 2495 (3866) 1359
(3743)
1136
Mean
QALYs
(SD)
0.644 (0.141) 0.643
(0.150)
0.001 0.632 (0.175) 0.633
(0.179)
-0.000
doi:10.1371/journal.pone.0152843.t008
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outcomes. At 10 months, carers in the reminiscence groups reported higher anxiety on the
GHQ sub-scale whilst those allocated to usual treatment showed a reduced level of anxiety at
this point. The compliance analysis suggests there are some benefits in terms of autobiographi-
cal memory, relationship quality and quality of life (EQ-5D) for people with dementia who
attend sessions as planned. This must however be viewed in the context of potential raised
stress in their carers and the lack of improvement on the dementia-specific quality of life mea-
sure (QoL-AD). The primary end point effectiveness results of this trial mean that the interven-
tion could not be cost-effective. There were few statistically significant differences in the
frequency and total cost of NHS, social care and voluntary sector service use between groups.
The intervention group reported using more local authority and NHS day care services and
day care hospital services than the control group over the ten month study period. It is not
clear why this should be the case; it is possible that increased social contact through attending
joint reminiscence groups may increase service uptake through improved knowledge of local
service provision and availability.
This is by far the largest rigorous trial of any reminiscence intervention for people with
dementia in the world literature and reports the first economic evaluation alongside a trial of
joint reminiscence groups. Group facilitators received training from the originator of the
approach and followed a detailed manual. The proportion of participants randomized to the
intervention and receiving it as planned over the ten month period was less than 60%, with
11% attending no group sessions at all and a quarter attending three or fewer sessions.
The current study systematically collected only a limited amount of process data, and rea-
sons for non-attendance are not clear. Attrition was greater in the treatment as usual group.
The compliance findings may reflect a 'survivor' effect, with those able to continue having
higher scores on certain measures, unrelated to the intervention. However, the analyses con-
trolled for baseline levels of each measure, as well as key demographic factors.
One of the challenges of research in dementia care is to balance the outcomes for people
with dementia and their carers, especially where these seem to potentially conflict. The current
study used a limited range of carer outcome measures, which tended to focus on negative out-
comes, rather than positive well-being. It is possible there may have been some benefits to car-
ers which were not measured.
The lack of positive results from this study is unexpected and contrasts with the findings
from our pilot trial platform [32] where 12 weeks of joint reminiscence groups were associated
with significant benefits to both autobiographical memory and to carer depression; the control
group showed a decline in these outcomes over the three months of the study, whereas those
receiving reminiscence maintained their baseline levels. Similarly, the Cochrane review [7] of
reminiscence for dementia also found significant improvements in cognition and mood after
4–6 weeks and reduced carer stress. The results are also not consistent with systematic reviews
[5] suggesting that involving people with dementia and carers together in an intervention leads
to better outcomes for family care-givers.
Three aspects are important to consider further, and are informed both by feedback which
was collected systematically as part of the programme, and by a qualitative study involving in-
depth interviews with 18 family carers who had attended RYCT groups in a subsequent study
[33]. Firstly, the lack of positive findings stands in contrast to the reported enjoyment and ben-
efits reported by participants and facilitators. Several groups chose to continue beyond the
funded ten-month period. Of 215 participants responding to a feedback survey at the end of
the weekly groups, all but 3 said that they would recommend the programme to a friend. There
is an argument that interventions for people with dementia should be evaluated in relation to
their immediate, within-session effects, rather than focusing on longer-term changes [34]. Sec-
ondly, despite signing up and consenting to a study involving reminiscence groups, many
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people did not take up the groups, or maintain attendance. For some, health problems or
change of circumstances limited attendance, but some carers expressed discomfort with groups
or expressed doubts about the potential benefits, and there were examples of people with
dementia enjoying the groups but being withdrawn by their carer who was less enthusiastic.
Outside the research context, joining such a group would be more a matter of personal prefer-
ence with perhaps scope for the person with dementia to attend alone. It appears that other
modalities for enhancing relationships between people with dementia and their carers need to
be explored. Thirdly, this study has highlighted increased anxiety in carers, with higher stress
reported by carers attending a greater number of group sessions. Examples of similar negative
effects have been reported in other studies where the carer has participated in a therapeutic
approach with the person with dementia [35,36]. The increased use of day care in the interven-
tion group may be relevant, with one study suggesting that day care may be associated with
lower carer mood [37]. Documented negative aspects of the intervention, from the perspectives
of carers include exposure to people with more advanced dementia offering an ‘unwelcome
vision of the future’; disappointment when the person responds well in the group, and then
returns to their usual condition later; lack of respite and lack of attention to the carer’s needs,
and feeling guilty at not being able to implement new skills learned in the group [33]. These
results should encourage reappraisal of the move towards encouraging joint interventions
which reflect the current emphasis on ‘relationship-centred care’ [38]. Many people did engage
with the intervention, and clearly enjoyed the activities and social aspects. The expectation that
interventions in dementia care should always have a sustained benefit outside the immediate
context may also need to be re-considered, so that clear expectations for participants and prac-
titioners may be established. Reminiscence may be one example of a leisure activity, enjoyed by
many, that can contribute to a rich and varied lifestyle for people with mild to moderate
dementia.
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